French biotech Abolis Biotechnologies has signed a strategic partnership with EUROAPI (EPA: EAPI) to develop microbial ...

The Association for Accessible Medicines (AAM) has filed for a federal injunction to prevent Connecticut from enforcing a new ...

A Swiss biotech company that applies quantum-informed science, causal biology, multi-omics and proprietary AI to early-stage ...

Research from GlobalData highlights the strength of Novartis' (NOVN: VX) position in IgA nephropathy (IgAN), following strong ...

Elixion Biotech has emerged from stealth with a breakthrough that it claims could reshape early-stage drug discovery.

The USA’s Institute for Clinical and Economic Review (ICER) today released its new “Launch Price and Access Report,” finding ...

South Korea’s Samsung Bioepis today released its Fourth Quarter 2025 Market Report, marking the eleventh edition of the ...

Alector’s ambitions for a breakthrough in rare dementia have been upended after its lead drug latozinemab (AL001), partnered ...

Swiss pharma giant Roche today released financial results for the first nine months of 2025, showing that group sales grew by ...

Florida, USA-based Summit Therapeutics announced that it has accepted offers from multiple leading biotech institutional and ...

US pharma major Pfizer (NYSE: PFE) has selected newly launched Expedition Medicines, a Flagship Pioneering company, as its ...

Japanese pharma major Astellas Pharma announced that the US Food and Drug Administration (FDA) accepted for priority review a ...